Chandler S. Cortina, MD, MS, FSSO, FACS

Assistant Professor


  • Froedtert Menomonee Falls Hospital
  • Froedtert Hospital
  • Froedtert West Bend Hospital
  • Cancer Center - Froedtert Hospital
  • Cancer Center - Froedtert Menomonee Falls Hospital


  • Surgical Oncology


  • English

Cancer Center - Froedtert Hospital

Cancer Center - Froedtert Menomonee Falls Hospital

New Patient Appointments - Benign Breast


  • MD - Doctor of Medicine
  • MS -Master of Science
  • FSSO-Fellow of the Society of Surgical Oncology
  • FACS - Fellow in the American College of Surgeons


Dr. Chandler Cortina was born and raised in Louisiana where he obtained his Bachelor of Science degree in Biochemistry at Louisiana State University and his Medical Degree from Louisiana State University Health Sciences Center. He then completed a residency in General Surgery at Rush University Medical Center and Cook County Hospital in Chicago, IL. Dr Cortina then completed a fellowship in Breast Surgical Oncology at the Lynn Sage Comprehensive Breast Center at Northwestern University and joined the Division of Surgical Oncology here at Froedtert and The Medical College of Wisconsin in September 2019 as a Breast Surgical Oncologist.

Research Areas of Interest

  • Breast Neoplasms
  • Cohort Studies
  • Early Detection of Cancer
  • Health Services for Transgender Persons
  • Healthcare Disparities
  • Intraoperative Care
  • Minority Health
  • Prospective Studies
  • Risk Factors
  • Sentinel Lymph Node Biopsy
  • Sexual and Gender Minorities

Clinical Expertise

  • Breast Neoplasms
  • Breast Neoplasms, Male
  • Health Services for the Aged
  • Mastectomy
  • Prophylactic Mastectomy
  • Risk Factors
  • Sentinel Lymph Node Biopsy
  • Transgender Persons
  • Triple Negative Breast Neoplasms

Research Interests

Dr. Chandler Cortina has strong passion for breast cancer outcomes research. His current research is focused on axillary management trends and the treatment of older adults with breast cancer. Dr. Cortina’s research also focuses on assessing both the potential risk and management of breast cancer in transgender persons.